<!DOCTYPE html>
<html lang="en-us">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <title>Epigenetic Regulation of Hepatitis B | Just for your understanding</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    
  </head>

  <body>
    <nav>
    <ul class="menu">
      
      <li><a href="/">Home</a></li>
      
      <li><a href="/about/">About</a></li>
      
      <li><a href="/categories/">Categories</a></li>
      
      <li><a href="/tags/">Tags</a></li>
      
      <li><a href="/index.xml">Subscribe</a></li>
      
    </ul>
    <hr/>
    </nav>

<div class="article-meta">
<h1><span class="title">Epigenetic Regulation of Hepatitis B</span></h1>
<h2 class="author">Zijian</h2>
<h2 class="date">2020/04/17</h2>
</div>

<main>
<p><strong>One major reason for failure of HBV treatment is the inability to eradicate or
inactivate the viral covalently closed circular DNA (cccDNA), which is a stable episomal form of the viral genome deco-
rated with host histones and nonhistone proteins</strong></p>
<p><strong>HBV cccDNA exists in the nucleus as
multiple copies of nucleosome-decorated minichromo-
somes</strong></p>
<p><strong>five nucleos(t)ide analogues (NUCs), including lamivudine, adefovir, entecavir, telbivudine, and tenofovir, that inhibit HBV reverse transcription</strong></p>
<p><strong>Epigenetic therapy, a novel strategy targeting
epigenetic modifications, was first applied successfully
to leukemia treatment.</strong></p>
<h1 id="hbv-life-cycle-and-cccdna-biology">HBV Life Cycle and cccDNA Biology</h1>
<ol>
<li>The mechanism by which the virus is endocytosed into the cytoplasm has not been completely demonstrated</li>
<li>The detailed molecular mechanisms of nucleocapsid disassembly and cccDNA biosynthesis remain elusive</li>
<li>Nucleosomes are nonrandomly positioned
on the cccDNA of duck HBV (DHBV)</li>
<li>The cccDNA minichromosome is stably maintained in quiescent hepatocytes with a long half-life and is responsible for the persistence of infection during the natural course of chronic infection and prolonged antiviral treatment.</li>
<li>cccDNA is inherently stable.</li>
</ol>
<h1 id="epigenetic-control-of-hbv-infection---dna-modificaiton">Epigenetic Control of HBV Infection - DNA modificaiton</h1>
<blockquote>
<p>DNA methylation only occurs on the nuclear HBV-DNA forms, but not the histone-free cytoplasmic core DNA or virion DNA.</p>
</blockquote>
<blockquote>
<p>the integration of HBV DNA into the human chromosome was frequently detected in HCCsfrom CHB patients. Integrated HBV
DNA are methylated and silenced in the SNU398 HCC cell line</p>
</blockquote>
<h1 id="histone-modifications-of-the-cccdna-minichromosome">HISTONE MODIFICATIONS OF THE CCCDNA MINICHROMOSOME</h1>
<p><strong>PTMs of histones and nonhistone proteins that either directly bind to cccDNA sequence or bind to cccDNA minichromosome through protein-protein interactions have become an active area of research</strong></p>

</main>

  <footer>
  <script src="//yihui.name/js/math-code.js"></script>
<script async src="//cdn.bootcss.com/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML"></script>

<script async src="//yihui.name/js/center-img.js"></script>

  
  <hr/>
  Â© <a href="https://zijzhang.netlify.com">Zijian Zhang</a> 2018 &ndash; 2019 | <a href="https://github.com/zijzhang">Github</a>
  
  </footer>
  </body>
</html>

